# First Horizon Corp: overview

FHN · NYSE · CIK 36966 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fhn.md) · [Financials](/companies/fhn/financials.md) · [Filings](/companies/fhn/filings.md) · [Insiders](/companies/fhn/insiders.md)

Latest reported revenue: [$887.0m](/filings/0000036966-26-000155.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:Revenues, accession 0000036966-26-000155).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [827](/filings/0000036966-25-000155.md) | [728 d](/filings/0000036966-26-000051.md) | [812](/filings/0000036966-26-000112.md) | [830](/filings/0000036966-26-000155.md) | [889](/filings/0000036966-25-000155.md) | [888 d](/filings/0000036966-26-000051.md) | [862](/filings/0000036966-26-000112.md) | [887](/filings/0000036966-26-000155.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [26.4%](/filings/0000036966-25-000155.md) | [22.8% d](/filings/0000036966-26-000051.md) | [26.8%](/filings/0000036966-26-000112.md) | [29.0%](/filings/0000036966-26-000155.md) | [29.5%](/filings/0000036966-25-000155.md) | [29.5% d](/filings/0000036966-26-000051.md) | [30.4%](/filings/0000036966-26-000112.md) | [30.4%](/filings/0000036966-26-000155.md) |
| Diluted EPS | $ per share | [0.40](/filings/0000036966-25-000155.md) | not reported | [0.41](/filings/0000036966-26-000112.md) | [0.45](/filings/0000036966-26-000155.md) | [0.50](/filings/0000036966-25-000155.md) | not reported | [0.53](/filings/0000036966-26-000112.md) | [0.54](/filings/0000036966-26-000155.md) |
| Free cash flow | $m | [383 d](/filings/0000036966-25-000155.md) | [174 d](/filings/0000036966-26-000051.md) | [340](/filings/0000036966-26-000112.md) | [74.0 d](/filings/0000036966-26-000155.md) | [(208) d](/filings/0000036966-25-000155.md) | [389 d](/filings/0000036966-26-000051.md) | [270](/filings/0000036966-26-000112.md) | [566 d](/filings/0000036966-26-000155.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | [3,207](/filings/0000036966-25-000024.md) | [3,467](/filings/0000036966-26-000051.md) | [3,190](/filings/0000036966-26-000051.md) | [3,419](/filings/0000036966-26-000051.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | [28.1%](/filings/0000036966-25-000024.md) | [25.9%](/filings/0000036966-26-000051.md) | [24.3%](/filings/0000036966-26-000051.md) | [28.7%](/filings/0000036966-26-000051.md) |
| Diluted EPS | $ per share | [1.74](/filings/0000036966-24-000015.md) | [1.53](/filings/0000036966-25-000024.md) | [1.54](/filings/0000036966-26-000051.md) | [1.36](/filings/0000036966-26-000051.md) | [1.87](/filings/0000036966-26-000051.md) |
| Free cash flow | $m | [688](/filings/0000036966-24-000015.md) | [2,263](/filings/0000036966-25-000024.md) | [1,262](/filings/0000036966-26-000051.md) | [1,224](/filings/0000036966-26-000051.md) | [595](/filings/0000036966-26-000051.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fhn/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.51bn | 58,706,667 |  | Added +1,546,691 |
| [Bank of New York Mellon Corp](/funds/1390777.md) | 2026-06-30 | $747.4m | 29,151,537 |  | Reduced −293,774 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $574.9m | 22,421,450 |  | Reduced −477,996 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $548.5m | 21,392,091 |  | Reduced −222,128 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $474.6m | 18,390,057 |  | Added +43,798 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $420.0m | 16,382,049 |  | Added +787,324 |
| [UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC](/funds/861177.md) | 2026-06-30 | $326.4m | 12,731,777 |  | Reduced −1,553,047 |
| [North Reef Capital Management LP](/funds/1867831.md) | 2026-06-30 | $235.9m | 9,201,256 |  | Reduced −5,251,952 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $232.2m | 9,052,528 |  | Reduced −76,800 |
| [AQR CAPITAL MANAGEMENT LLC](/funds/1167557.md) | 2026-06-30 | $224.9m | 8,832,027 |  | Added +1,286,274 |

## Recent filings

[All 2,281 filings](/companies/fhn/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 07:31 ET | [8-K](/filings/0000036966-26-000178.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036966-26-000178 |
| 2026-08-06 | 16:17 ET | [10-Q](/filings/0000036966-26-000155.md) | Quarterly report, period 2026-06-30 | 0000036966-26-000155 |
| 2026-07-28 | 16:31 ET | [8-K](/filings/0000036966-26-000149.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000036966-26-000149 |
| 2026-07-15 | 06:32 ET | [8-K](/filings/0000036966-26-000143.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036966-26-000143 |
| 2026-05-07 | 16:14 ET | [10-Q](/filings/0000036966-26-000112.md) | Quarterly report, period 2026-03-31 | 0000036966-26-000112 |
| 2026-04-29 | 16:06 ET | [8-K](/filings/0000036966-26-000070.md) | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0000036966-26-000070 |
| 2026-04-15 | 06:32 ET | [8-K](/filings/0000036966-26-000067.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000036966-26-000067 |
| 2026-03-16 | 16:20 ET | [DEF 14A](/filings/0000036966-26-000063.md) | Proxy statement, period 2026-04-28 | 0000036966-26-000063 |
| 2026-03-12 | 16:22 ET | [8-K](/filings/0000930413-26-000749.md) | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000930413-26-000749 |
| 2026-02-26 | 16:12 ET | [10-K](/filings/0000036966-26-000051.md) | Annual report, period 2025-12-31 | 0000036966-26-000051 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000036966-26-000051.md), filed Feb 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 36966
- Tickers: FHN, FHN-PE, FHN-PF, FHN-PH
- Exchange: NYSE
- SIC code: 6021 National Commercial Banks
- State of incorporation: TN
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 06:18 ET. No prices; not investment advice.